- 专利标题： Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
-
申请号： US12706326申请日： 2010-02-16
-
公开(公告)号： US08563617B2公开(公告)日： 2013-10-22
- 发明人: Wilhelm Amberg , Michael Ochse , Udo Lange , Andreas Kling , Berthold Behl , Wilfried Homberger , Mario Mezler , Charles W. Hutchins
- 申请人： Wilhelm Amberg , Michael Ochse , Udo Lange , Andreas Kling , Berthold Behl , Wilfried Homberger , Mario Mezler , Charles W. Hutchins
- 申请人地址： DE Wiesbaden US IL Abbott Park
- 专利权人： AbbVie Deutschland GmbH & Co. KG,Abbott Laboratories
- 当前专利权人： AbbVie Deutschland GmbH & Co. KG,Abbott Laboratories
- 当前专利权人地址： DE Wiesbaden US IL Abbott Park
- 代理机构： Michael Best & Friedrich LLP
- 代理商 Lisa V. Mueller
- 主分类号： A61K31/16
- IPC分类号： A61K31/16 ; C07C215/70
摘要：
The present invention relates to aminotetraline derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminotetraline derivatives, and the use of such aminotetraline derivatives for therapeutic purposes. The aminotetraline derivatives are GlyT1 inhibitors.
公开/授权文献
信息查询
